InvestorsHub Logo

Drugdoctor

08/17/17 9:36 PM

#687 RE: 66 #686

we generated net loss of $(4,383,271) during the six months ended June 30, 2017 (approximately ($0.22) per share), compared to net loss of $(219,118) during the six months ended June 30, 2016. Of this net loss, we note that $4,480,318 was related to extraordinary one-time costs related to stock compensation.

JohnCM

12/22/17 7:35 AM

#715 RE: 66 #686

including a one-time stock compensation expense of $4,480,318


One off?